Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Open in API
Filings indexed 1,568 across all filing types
Latest filing 2026-01-21 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT POSSIBLE COOPERATION FOR LOCALISATION IN THE PRC
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement regarding a memorandum of understanding (MOU) for a 'Possible Cooperation' between Sisram Medical Ltd and Sinmait Medical Technology. It discusses strategic localization in the PRC and potential connected transactions under the Listing Rules. Since it does not fit into specific categories like M&A (which usually implies a definitive agreement or takeover bid) or other financial reporting categories, and it is a general regulatory announcement regarding company strategy and potential future transactions, it falls under the RNS (Regulatory Filings) category.
2026-01-21 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
Share Issue/Capital Change Classification · 95% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for issuers to report monthly movements in securities, including share capital, issued shares, and treasury shares. Since it is a recurring regulatory filing regarding share capital and securities movements that does not fit into specific categories like 'Share Issue' (which usually implies a specific event) or 'Transaction in Own Shares' (which is for specific buybacks), it is best classified as a Regulatory Filing (RNS).
2026-01-06 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement from Sisram Medical Ltd regarding the successful quality testing of a new product (DAXXIFY) in China. It does not report financial results, board changes, or dividend declarations, nor is it a report publication announcement. As it is a general corporate update regarding business operations and product development that does not fit into specific categories like M&A or legal proceedings, it falls under the general regulatory announcement category.
2026-01-05 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2025
Share Issue/Capital Change Classification · 95% confidence The document is a 'Monthly Return for Equity Issuer' filed with the Hong Kong Exchanges and Clearing Limited. This is a standard regulatory filing required by the HKEX for listed companies to report movements in their securities, share capital, and treasury shares on a monthly basis. It does not fit into specific categories like 'Share Issue' (which is usually a specific event announcement) or 'Annual Report', but rather serves as a recurring regulatory disclosure of capital structure. Therefore, it is classified as a Regulatory Filing (RNS).
2026-01-02 English
VOLUNTARY ANNOUNCEMENT - ENTERING INTO A COOPERATION AGREEMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement regarding a business cooperation agreement between a subsidiary of the company and a third party. It does not fit into specific categories like M&A (which usually involves takeovers or mergers), financial reporting, or dividend announcements. As it is a general regulatory announcement regarding business development that does not fall into the other specialized categories, it is classified as a Regulatory Filing (RNS).
2025-12-22 English
Interim Report 2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report 2025' for Reliance Global Holdings Limited. It contains comprehensive financial statements, including the 'Condensed Consolidated Statement of Profit or Loss', 'Condensed Consolidated Statement of Financial Position', and 'Notes to the Condensed Consolidated Interim Financial Statements'. It also includes a detailed 'Management Discussion and Analysis' section. As it covers a period shorter than a full fiscal year (six months ended 30 September 2025) and contains substantive financial data, it is classified as an Interim/Quarterly Report. H1 2025
2025-12-17 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.